NTRR: Huge Opportunities for Innovation Loom in Billion Dollar Cannabis Markets

NTRR: Huge Opportunities for Innovation Loom in Billion Dollar Cannabis Markets

SARASOTA, Fla.--(BUSINESS WIRE)-- Even as lucrative new markets for medical marijuana continue to open up across North America, in many cases, patients don't know much more about the cannabis they're buying and consuming than the name of the strain. Neutra Corp. (OTCBB: NTRR) is exploring ways to change that.

Currently, the medical marijuana market in the U.S. is worth $1.7 billion. With more cannabis legislation now on the table from coast to coast, most industry experts agree that figure will rise. NTRR is looking for new technologies that will put the company on the cutting edge of cannabis-related products and services.

In order for patients to achieve consistent results with medical marijuana, they must know the potency of the drug's active ingredients, including THC, cannabidiol (CBD) and cannabinol (CBN). This information would also allow state governments to regulate medicinal cannabis more effectively and let dispensaries differentiate products for pricing purposes.

Thanks to a boom in interest in medical marijuana, labs are popping up across the U.S. capable of delivering this important information. The laboratories with access to the most advanced technology for testing should capture a significant share of the testing market, says NTRR CEO Cindy Morrissey, because they'll be better equipped to quickly and efficiently handle large volumes of cannabis.

"Patients use this crucial information to better predict how marijuana will help them, and to be sure that their marijuana is free of harmful pathogens, residue, pesticides and debris, which is important if you're suffering from a serious illness," she said. "Growers can use this lab data to monitor and upgrade their cultivation techniques. So, the market is there and growing for these testing innovations, and we're seeking out potential partners who can help us deliver them."

Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing medical marijuana sector alongside Cannabis Science Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA), HEMP Inc. (PINK: HEMP) and Growlife Inc. (PINK: PHOT).

For more information on NTRR's initiatives, please visit www.neutracorp.com/investors.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Cindy Morrissey, 713-821-1486
President and CEO
info@neutracorp.com

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS:

The article NTRR: Huge Opportunities for Innovation Loom in Billion Dollar Cannabis Markets originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.